Professional Documents
Culture Documents
PC 2020
PC 2020
Methodology
Data for application
Results
Conclusions and Recommendations
October 1, 2020
Stephen Jun Villejo Bayesian Modelling of Incidence of Certain Diseases in the Philipp
Introduction
Methodology
Data for application
Results
Conclusions and Recommendations
Outline
Stephen Jun Villejo Bayesian Modelling of Incidence of Certain Diseases in the Philipp
Introduction
Methodology
Introduction
Data for application
Objectives
Results
Conclusions and Recommendations
Introduction
Disease mapping is a
primary goal in
epidemiology.
Disease maps enable us to
visualize the degree,
magnitude, and intensity of
the disease.
Efficient disease maps can
be automated to provide
real-time outbreak alerts for
surveillance of diseases.
Stephen Jun Villejo Bayesian Modelling of Incidence of Certain Diseases in the Philipp
Introduction
Methodology
Introduction
Data for application
Objectives
Results
Conclusions and Recommendations
Introduction
Stephen Jun Villejo Bayesian Modelling of Incidence of Certain Diseases in the Philipp
Introduction
Methodology
Introduction
Data for application
Objectives
Results
Conclusions and Recommendations
Introduction
Stephen Jun Villejo Bayesian Modelling of Incidence of Certain Diseases in the Philipp
Introduction
Methodology
Introduction
Data for application
Objectives
Results
Conclusions and Recommendations
Stephen Jun Villejo Bayesian Modelling of Incidence of Certain Diseases in the Philipp
Introduction Conditionally Autoregressive Models
Methodology Hierarchical Spatial Model
Data for application Prior specifications
Results Bayesian computation
Conclusions and Recommendations Model goodness-of-fit and convergence
Stephen Jun Villejo Bayesian Modelling of Incidence of Certain Diseases in the Philipp
Introduction Conditionally Autoregressive Models
Methodology Hierarchical Spatial Model
Data for application Prior specifications
Results Bayesian computation
Conclusions and Recommendations Model goodness-of-fit and convergence
Stephen Jun Villejo Bayesian Modelling of Incidence of Certain Diseases in the Philipp
Introduction Conditionally Autoregressive Models
Methodology Hierarchical Spatial Model
Data for application Prior specifications
Results Bayesian computation
Conclusions and Recommendations Model goodness-of-fit and convergence
Stephen Jun Villejo Bayesian Modelling of Incidence of Certain Diseases in the Philipp
Introduction Conditionally Autoregressive Models
Methodology Hierarchical Spatial Model
Data for application Prior specifications
Results Bayesian computation
Conclusions and Recommendations Model goodness-of-fit and convergence
wij τ2
and τi2 =
P
We set bij = , where wi+ = j wij .
wi+ wi+
This will yield
X w y τ2
ij j
Yi |yj , j 6= i ∼ N , , i = 1, ..., n.
wi+ wi+
j
Stephen Jun Villejo Bayesian Modelling of Incidence of Certain Diseases in the Philipp
Introduction Conditionally Autoregressive Models
Methodology Hierarchical Spatial Model
Data for application Prior specifications
Results Bayesian computation
Conclusions and Recommendations Model goodness-of-fit and convergence
Σ−1
y = Dw − W is singular and so Σy does not exist.
The model above is also called the intrinsically autoregressive
(IAR) model.
One solution to the impropriety of the joint distribution above
is to incorporate a new parameter ρ and define
Σ−1 −1
y = Dw − ρW to make Σy nonsingular.
Stephen Jun Villejo Bayesian Modelling of Incidence of Certain Diseases in the Philipp
Introduction Conditionally Autoregressive Models
Methodology Hierarchical Spatial Model
Data for application Prior specifications
Results Bayesian computation
Conclusions and Recommendations Model goodness-of-fit and convergence
Stephen Jun Villejo Bayesian Modelling of Incidence of Certain Diseases in the Philipp
Introduction Conditionally Autoregressive Models
Methodology Hierarchical Spatial Model
Data for application Prior specifications
Results Bayesian computation
Conclusions and Recommendations Model goodness-of-fit and convergence
Yk |ηk ∼ Po(Ek ηk )
log(ηk ) = xT
k β + ψk
ψ ∼ g (.|θψ )
β ∼ N(µβ , Σβ )
Stephen Jun Villejo Bayesian Modelling of Incidence of Certain Diseases in the Philipp
Introduction Conditionally Autoregressive Models
Methodology Hierarchical Spatial Model
Data for application Prior specifications
Results Bayesian computation
Conclusions and Recommendations Model goodness-of-fit and convergence
Yk
η̂k ≡ SIRk =
Ek
Stephen Jun Villejo Bayesian Modelling of Incidence of Certain Diseases in the Philipp
Introduction Conditionally Autoregressive Models
Methodology Hierarchical Spatial Model
Data for application Prior specifications
Results Bayesian computation
Conclusions and Recommendations Model goodness-of-fit and convergence
Stephen Jun Villejo Bayesian Modelling of Incidence of Certain Diseases in the Philipp
Introduction Conditionally Autoregressive Models
Methodology Hierarchical Spatial Model
Data for application Prior specifications
Results Bayesian computation
Conclusions and Recommendations Model goodness-of-fit and convergence
ψk = φk + θk
PK !
w φ τ 2
ki i
φk |φ−k , W, τ 2 ∼ N Pi=1K
, PK
i=1 wki i=1 wki
θk ∼ N(0, σ 2 )
τ 2 ∼ Inverse-Gamma(a1 , b1 )
σ 2 ∼ Inverse-Gamma(a2 , b2 )
Stephen Jun Villejo Bayesian Modelling of Incidence of Certain Diseases in the Philipp
Introduction Conditionally Autoregressive Models
Methodology Hierarchical Spatial Model
Data for application Prior specifications
Results Bayesian computation
Conclusions and Recommendations Model goodness-of-fit and convergence
Stephen Jun Villejo Bayesian Modelling of Incidence of Certain Diseases in the Philipp
Introduction Conditionally Autoregressive Models
Methodology Hierarchical Spatial Model
Data for application Prior specifications
Results Bayesian computation
Conclusions and Recommendations Model goodness-of-fit and convergence
ψ k = φk
PK !
ρ w φ τ 2
ki i
φk |φ−k , W, τ 2 , ρ ∼ N P i=1 , P
ρ K w
i=1 ki + 1−ρ ρ K
i=1 wki + 1 − ρ
τ 2 ∼ Inverse-Gamma(a, b)
ρ ∼ Uniform(0, 1)
Stephen Jun Villejo Bayesian Modelling of Incidence of Certain Diseases in the Philipp
Introduction Conditionally Autoregressive Models
Methodology Hierarchical Spatial Model
Data for application Prior specifications
Results Bayesian computation
Conclusions and Recommendations Model goodness-of-fit and convergence
Stephen Jun Villejo Bayesian Modelling of Incidence of Certain Diseases in the Philipp
Introduction Conditionally Autoregressive Models
Methodology Hierarchical Spatial Model
Data for application Prior specifications
Results Bayesian computation
Conclusions and Recommendations Model goodness-of-fit and convergence
Stephen Jun Villejo Bayesian Modelling of Incidence of Certain Diseases in the Philipp
Introduction Conditionally Autoregressive Models
Methodology Hierarchical Spatial Model
Data for application Prior specifications
Results Bayesian computation
Conclusions and Recommendations Model goodness-of-fit and convergence
Bayesian Computation
Stephen Jun Villejo Bayesian Modelling of Incidence of Certain Diseases in the Philipp
Introduction Conditionally Autoregressive Models
Methodology Hierarchical Spatial Model
Data for application Prior specifications
Results Bayesian computation
Conclusions and Recommendations Model goodness-of-fit and convergence
Bayesian Computation
Stephen Jun Villejo Bayesian Modelling of Incidence of Certain Diseases in the Philipp
Introduction Conditionally Autoregressive Models
Methodology Hierarchical Spatial Model
Data for application Prior specifications
Results Bayesian computation
Conclusions and Recommendations Model goodness-of-fit and convergence
Bayesian Computation
Stephen Jun Villejo Bayesian Modelling of Incidence of Certain Diseases in the Philipp
Introduction Conditionally Autoregressive Models
Methodology Hierarchical Spatial Model
Data for application Prior specifications
Results Bayesian computation
Conclusions and Recommendations Model goodness-of-fit and convergence
Bayesian Computation
Stephen Jun Villejo Bayesian Modelling of Incidence of Certain Diseases in the Philipp
Introduction Conditionally Autoregressive Models
Methodology Hierarchical Spatial Model
Data for application Prior specifications
Results Bayesian computation
Conclusions and Recommendations Model goodness-of-fit and convergence
Model goodness-of-fit
Moran’s I on residuals
Moran’s I is a standard statistic to measure strength of spatial
association among areal units.
Deviance Information Criterion (DIC)
DIC is a somewhat Bayesian version of AIC.
Watanabe-Akaike Information Criterion (WAIC)
WAIC is a more fully Bayesian approach.
It is helpful for models with hierarchical and mixture structures
in which the number of parameters increases with sample size.
Stephen Jun Villejo Bayesian Modelling of Incidence of Certain Diseases in the Philipp
Introduction Conditionally Autoregressive Models
Methodology Hierarchical Spatial Model
Data for application Prior specifications
Results Bayesian computation
Conclusions and Recommendations Model goodness-of-fit and convergence
Convergence diagnosis
Plot the m thinned sampling chains on a common set of axes
and observe if there is a good amount of ”overlapping” or
”mixing”. This is called a trace plot.
Figure: Trace plot of two chains run with different starting values
Stephen Jun Villejo Bayesian Modelling of Incidence of Certain Diseases in the Philipp
Introduction Conditionally Autoregressive Models
Methodology Hierarchical Spatial Model
Data for application Prior specifications
Results Bayesian computation
Conclusions and Recommendations Model goodness-of-fit and convergence
Convergence diagnosis
Stephen Jun Villejo Bayesian Modelling of Incidence of Certain Diseases in the Philipp
Introduction
Methodology
Data for application
Results
Conclusions and Recommendations
Stephen Jun Villejo Bayesian Modelling of Incidence of Certain Diseases in the Philipp
Introduction
Methodology
Data for application
Results
Conclusions and Recommendations
Stephen Jun Villejo Bayesian Modelling of Incidence of Certain Diseases in the Philipp
Introduction CAR BYM Model
Methodology Leroux Model
Data for application CAR Dissimilarity Model (Binary)
Results CAR Dissimilarity Model (Non-binary)
Conclusions and Recommendations CAR localised model (G = 3))
All the scale reduction factors are less than 1.1. ψ̂1 has a
Geweke statistic greater than 1.96.
Stephen Jun Villejo Bayesian Modelling of Incidence of Certain Diseases in the Philipp
Introduction CAR BYM Model
Methodology Leroux Model
Data for application CAR Dissimilarity Model (Binary)
Results CAR Dissimilarity Model (Non-binary)
Conclusions and Recommendations CAR localised model (G = 3))
Stephen Jun Villejo Bayesian Modelling of Incidence of Certain Diseases in the Philipp
Introduction CAR BYM Model
Methodology Leroux Model
Data for application CAR Dissimilarity Model (Binary)
Results CAR Dissimilarity Model (Non-binary)
Conclusions and Recommendations CAR localised model (G = 3))
Stephen Jun Villejo Bayesian Modelling of Incidence of Certain Diseases in the Philipp
Introduction CAR BYM Model
Methodology Leroux Model
Data for application CAR Dissimilarity Model (Binary)
Results CAR Dissimilarity Model (Non-binary)
Conclusions and Recommendations CAR localised model (G = 3))
Stephen Jun Villejo Bayesian Modelling of Incidence of Certain Diseases in the Philipp
Introduction CAR BYM Model
Methodology Leroux Model
Data for application CAR Dissimilarity Model (Binary)
Results CAR Dissimilarity Model (Non-binary)
Conclusions and Recommendations CAR localised model (G = 3))
Figure: Plot of η̂i = exp{β̂0 + ψ̂i }. Figure: Plot of the MLEs of SIR.
Stephen Jun Villejo Bayesian Modelling of Incidence of Certain Diseases in the Philipp
Introduction CAR BYM Model
Methodology Leroux Model
Data for application CAR Dissimilarity Model (Binary)
Results CAR Dissimilarity Model (Non-binary)
Conclusions and Recommendations CAR localised model (G = 3))
Figure: BYM relative risks and MLE of SIR, and the corresponding 95%
confidence/equal-tailed interval.
Stephen Jun Villejo Bayesian Modelling of Incidence of Certain Diseases in the Philipp
Introduction CAR BYM Model
Methodology Leroux Model
Data for application CAR Dissimilarity Model (Binary)
Results CAR Dissimilarity Model (Non-binary)
Conclusions and Recommendations CAR localised model (G = 3))
Leroux Model
All the scale reduction factors for ψi are less than 1.1. The
Geweke statistics also suggest convergence.
Stephen Jun Villejo Bayesian Modelling of Incidence of Certain Diseases in the Philipp
Introduction CAR BYM Model
Methodology Leroux Model
Data for application CAR Dissimilarity Model (Binary)
Results CAR Dissimilarity Model (Non-binary)
Conclusions and Recommendations CAR localised model (G = 3))
Leroux Model
Stephen Jun Villejo Bayesian Modelling of Incidence of Certain Diseases in the Philipp
Introduction CAR BYM Model
Methodology Leroux Model
Data for application CAR Dissimilarity Model (Binary)
Results CAR Dissimilarity Model (Non-binary)
Conclusions and Recommendations CAR localised model (G = 3))
Leroux Model
Stephen Jun Villejo Bayesian Modelling of Incidence of Certain Diseases in the Philipp
Introduction CAR BYM Model
Methodology Leroux Model
Data for application CAR Dissimilarity Model (Binary)
Results CAR Dissimilarity Model (Non-binary)
Conclusions and Recommendations CAR localised model (G = 3))
Leroux Model
Stephen Jun Villejo Bayesian Modelling of Incidence of Certain Diseases in the Philipp
Introduction CAR BYM Model
Methodology Leroux Model
Data for application CAR Dissimilarity Model (Binary)
Results CAR Dissimilarity Model (Non-binary)
Conclusions and Recommendations CAR localised model (G = 3))
Leroux Model
Figure: Plot of η̂i = exp{β̂0 + ψ̂i }. Figure: Plot of the MLEs of SIR.
Stephen Jun Villejo Bayesian Modelling of Incidence of Certain Diseases in the Philipp
Introduction CAR BYM Model
Methodology Leroux Model
Data for application CAR Dissimilarity Model (Binary)
Results CAR Dissimilarity Model (Non-binary)
Conclusions and Recommendations CAR localised model (G = 3))
Leroux Model
Figure: Leroux relative risks and MLE of SIR, and the corresponding 95%
confidence/equal-tailed interval.
Stephen Jun Villejo Bayesian Modelling of Incidence of Certain Diseases in the Philipp
Introduction CAR BYM Model
Methodology Leroux Model
Data for application CAR Dissimilarity Model (Binary)
Results CAR Dissimilarity Model (Non-binary)
Conclusions and Recommendations CAR localised model (G = 3))
Stephen Jun Villejo Bayesian Modelling of Incidence of Certain Diseases in the Philipp
Introduction CAR BYM Model
Methodology Leroux Model
Data for application CAR Dissimilarity Model (Binary)
Results CAR Dissimilarity Model (Non-binary)
Conclusions and Recommendations CAR localised model (G = 3))
Stephen Jun Villejo Bayesian Modelling of Incidence of Certain Diseases in the Philipp
Introduction CAR BYM Model
Methodology Leroux Model
Data for application CAR Dissimilarity Model (Binary)
Results CAR Dissimilarity Model (Non-binary)
Conclusions and Recommendations CAR localised model (G = 3))
Stephen Jun Villejo Bayesian Modelling of Incidence of Certain Diseases in the Philipp
Introduction CAR BYM Model
Methodology Leroux Model
Data for application CAR Dissimilarity Model (Binary)
Results CAR Dissimilarity Model (Non-binary)
Conclusions and Recommendations CAR localised model (G = 3))
Stephen Jun Villejo Bayesian Modelling of Incidence of Certain Diseases in the Philipp
Introduction CAR BYM Model
Methodology Leroux Model
Data for application CAR Dissimilarity Model (Binary)
Results CAR Dissimilarity Model (Non-binary)
Conclusions and Recommendations CAR localised model (G = 3))
Figure: Dissimilarity (binary) model relative risks and MLE of SIR, and
the corresponding 95% confidence/equal-tailed interval.
Stephen Jun Villejo Bayesian Modelling of Incidence of Certain Diseases in the Philipp
Introduction CAR BYM Model
Methodology Leroux Model
Data for application CAR Dissimilarity Model (Binary)
Results CAR Dissimilarity Model (Non-binary)
Conclusions and Recommendations CAR localised model (G = 3))
Stephen Jun Villejo Bayesian Modelling of Incidence of Certain Diseases in the Philipp
Introduction CAR BYM Model
Methodology Leroux Model
Data for application CAR Dissimilarity Model (Binary)
Results CAR Dissimilarity Model (Non-binary)
Conclusions and Recommendations CAR localised model (G = 3))
Stephen Jun Villejo Bayesian Modelling of Incidence of Certain Diseases in the Philipp
Introduction CAR BYM Model
Methodology Leroux Model
Data for application CAR Dissimilarity Model (Binary)
Results CAR Dissimilarity Model (Non-binary)
Conclusions and Recommendations CAR localised model (G = 3))
Stephen Jun Villejo Bayesian Modelling of Incidence of Certain Diseases in the Philipp
Introduction CAR BYM Model
Methodology Leroux Model
Data for application CAR Dissimilarity Model (Binary)
Results CAR Dissimilarity Model (Non-binary)
Conclusions and Recommendations CAR localised model (G = 3))
Stephen Jun Villejo Bayesian Modelling of Incidence of Certain Diseases in the Philipp
Introduction CAR BYM Model
Methodology Leroux Model
Data for application CAR Dissimilarity Model (Binary)
Results CAR Dissimilarity Model (Non-binary)
Conclusions and Recommendations CAR localised model (G = 3))
Stephen Jun Villejo Bayesian Modelling of Incidence of Certain Diseases in the Philipp
Introduction CAR BYM Model
Methodology Leroux Model
Data for application CAR Dissimilarity Model (Binary)
Results CAR Dissimilarity Model (Non-binary)
Conclusions and Recommendations CAR localised model (G = 3))
Stephen Jun Villejo Bayesian Modelling of Incidence of Certain Diseases in the Philipp
Introduction CAR BYM Model
Methodology Leroux Model
Data for application CAR Dissimilarity Model (Binary)
Results CAR Dissimilarity Model (Non-binary)
Conclusions and Recommendations CAR localised model (G = 3))
Stephen Jun Villejo Bayesian Modelling of Incidence of Certain Diseases in the Philipp
Introduction CAR BYM Model
Methodology Leroux Model
Data for application CAR Dissimilarity Model (Binary)
Results CAR Dissimilarity Model (Non-binary)
Conclusions and Recommendations CAR localised model (G = 3))
Stephen Jun Villejo Bayesian Modelling of Incidence of Certain Diseases in the Philipp
Introduction CAR BYM Model
Methodology Leroux Model
Data for application CAR Dissimilarity Model (Binary)
Results CAR Dissimilarity Model (Non-binary)
Conclusions and Recommendations CAR localised model (G = 3))
Stephen Jun Villejo Bayesian Modelling of Incidence of Certain Diseases in the Philipp
Introduction
Methodology
Data for application
Results
Conclusions and Recommendations
Stephen Jun Villejo Bayesian Modelling of Incidence of Certain Diseases in the Philipp
Introduction
Methodology
Data for application
Results
Conclusions and Recommendations
Stephen Jun Villejo Bayesian Modelling of Incidence of Certain Diseases in the Philipp
Introduction
Methodology
Data for application
Results
Conclusions and Recommendations
References
Besag, J. (1974). Spatial interaction and the statistical analysis of lattice
systems. Journal of the Royal Statistical Society B, 36: 192-236.
Brook, D. (1964). On the distinction between the conditional probability
and the joint probability approaches in the specification of
nearest-neighbour system. Biometrika, 51: 481-483.
Leoroux, B., Lei, X., and Breslow, N. (2000) Estimation of disease rates
in small areas: a new mixed model for spatial dependence. In: Halloran
ME, Berry D (eds). Statistical models in epidemiology, the environment,
and clinical trials. New York: Springer, 1135-178.
Lee, D., Mitchell R. (2012) Air Pollution and Health in Scotland: A
Multicity Study. Biostatistics, 10:409-423
Lee, D., Sarran, C. (2015). Controlling for unmeasured confounding and
spatial misalignment in long-term air pollution and health studies.
Environmentrics, 26:477-487
Geweke, J. (1992) Evaluating the accuracy of sampling-based approaches
to the calculation of posterior moments. In In Bayesian Statistics pp
169-193. University Press.
Stephen Jun Villejo Bayesian Modelling of Incidence of Certain Diseases in the Philipp
Introduction
Methodology
Data for application
Results
Conclusions and Recommendations
THANK YOU!
Stephen Jun Villejo Bayesian Modelling of Incidence of Certain Diseases in the Philipp